Latka logo
GC Therapeutics logo

GC Therapeuticsrevenue

Cambridge, MassachusettsFounded 2019CEO Edward Trahearn

GC Therapeutics (GCTx) uses synthetic biology to program patient-derived stem cells into various cell types in an efficient and scalable manner, aiming to revolutionize treatment across a broad range of therapeutic areas.

gc-tx.comLinkedInUpdated Sep 10, 2026
Annual revenue
$9.6M
Sep 2025EST
Employees
42
Sep 2025

GC Therapeutics revenue

GC Therapeutics has not published its revenue. Growjo puts it at about $9.6M a year (September 2025).

$0
$2.5M
$5M
$7.5M
$0
–
$9.6M
20192020–242025
ReportedEstimateFounded 2019 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$9.6MESTGrowjo estimate

GC Therapeutics CEO & employees

Edward Trahearn is CEO of GC Therapeutics. GC Therapeutics has 42 employees (September 2025, LinkedIn).

0
20
40
42
2025
ReportedOne figure per year; a reported figure wins over an estimate

GC Therapeutics FAQ

What is GC Therapeutics' revenue?

Growjo estimates GC Therapeutics' revenue at about $9.6M a year (September 2025). The company hasn't published its own figure.

How many employees does GC Therapeutics have?

GC Therapeutics has 42 employees as of September 2025, according to LinkedIn.

Who is the CEO of GC Therapeutics?

Edward Trahearn is the CEO of GC Therapeutics.

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun GC Therapeutics? Join the podcast